Time to Uveitis Control with Methotrexate and Mycophenolate Mofetil

Affiliations

• ¹ Department of Ophthalmology, University of California, San Francisco, San Francisco, California.
• ² F. I. Proctor Foundation, University of California, San Francisco, San Francisco, California.
• ³ Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Madurai, India.
• ⁴ Department of Ophthalmology, University of California, San Francisco, San Francisco, California; F. I. Proctor Foundation, University of California, San Francisco, San Francisco, California.
• ⁵ Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Coimbatore, India.
• ⁶ Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Pondicherry, India.
• ⁷ Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia.
• ⁸ Casey Eye Institute, Oregon Health and Science University, OHSU-PSU School of Public Health, and Portland Veterans' Affairs Health Care System, Portland, Oregon.
• ⁹ Division of Vitreoretinal Surgery and Uveitis, King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia.
• ¹⁰ Department of Ophthalmology, University of California, San Francisco, San Francisco, California; F. I. Proctor Foundation, University of California, San Francisco, San Francisco, California; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California. Electronic address: Nisha.Acharya@ucsf.edu.